Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities

Neuropharmacology. 2009 Oct-Nov;57(5-6):567-76. doi: 10.1016/j.neuropharm.2009.07.011. Epub 2009 Jul 15.

Abstract

5-HT(1A) receptors are implicated in the modulation of cognitive processes including encoding of fear learning. However, their exact role has remained unclear due to contrasting contributions of pre- vs. postsynaptic 5-HT(1A) receptors. Therefore, their role in fear conditioning was studied in mice using the selective ligand S15535, which fully activates 5-HT(1A) autoreceptors, yet only weakly stimulates their postsynaptic counterparts. The effects of S15535 were compared to those of the full agonist 8-OH-DPAT and the selective antagonist NAD-299. 8-OH-DPAT dose-dependently (0.01-0.5 mg/kg) and markedly impaired both context- and tone-dependent fear conditioning, as determined by complementary measures of inactivity and freezing. 8-OH-DPAT-mediated impairments were blocked by pre-injection of the selective 5-HT(1A) antagonist WAY100635. S15535 (0.01-5.0 mg/kg) mimicked 8-OH-DPAT in predominantly impairing conditioned contextual fear, though with smaller effect size than 8-OH-DPAT, consistent with lower efficacy at postsynaptic 5-HT(1A) receptors. Furthermore, S15535 (1.0 mg/kg) tended to attenuate the impairment of fear conditioning by 8-OH-DPAT (0.3 mg/kg). In contrast, NAD-299 (0.3 and 1 mg/kg) facilitated contextual freezing. WAY100635 (0.3 mg/kg) prevented the impairment of contextual fear by S15535 (1 and 5 mg/kg), underpinning the role of 5-HT(1A) receptors in the actions of S15535. Collectively, these data indicate that 5-HT(1A) receptor ligands modulate fear conditioning in a bidirectional manner: activation of postsynaptic 5-HT(1A) sites exerts an inhibitory influence, whereas their blockade promote facilitation of fear conditioning. The results with S15535 underscore the importance of ligand efficacy in determining the actions of 5-HT(1A) receptor ligands in fear conditioning and other models of cognitive function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 8-Hydroxy-2-(di-n-propylamino)tetralin / administration & dosage
  • 8-Hydroxy-2-(di-n-propylamino)tetralin / pharmacology
  • Animals
  • Benzopyrans / pharmacology
  • Central Nervous System Agents / pharmacology
  • Conditioning, Classical / drug effects*
  • Conditioning, Classical / physiology
  • Dose-Response Relationship, Drug
  • Fear*
  • Ligands
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Neurons / drug effects*
  • Neurons / physiology
  • Piperazines / administration & dosage
  • Piperazines / pharmacology
  • Presynaptic Terminals / drug effects*
  • Presynaptic Terminals / physiology
  • Pyridines / administration & dosage
  • Pyridines / pharmacology
  • Receptor, Serotonin, 5-HT1A / metabolism*
  • Serotonin 5-HT1 Receptor Agonists
  • Serotonin 5-HT1 Receptor Antagonists
  • Serotonin Antagonists / pharmacology
  • Serotonin Receptor Agonists / administration & dosage
  • Serotonin Receptor Agonists / pharmacology
  • Synapses / drug effects
  • Synapses / physiology
  • Time Factors

Substances

  • Benzopyrans
  • Central Nervous System Agents
  • Ligands
  • Piperazines
  • Pyridines
  • Serotonin 5-HT1 Receptor Agonists
  • Serotonin 5-HT1 Receptor Antagonists
  • Serotonin Antagonists
  • Serotonin Receptor Agonists
  • Receptor, Serotonin, 5-HT1A
  • 4-(benzodioxan-5-yl)-1-(indan-2-yl)piperazine
  • N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide
  • 8-Hydroxy-2-(di-n-propylamino)tetralin
  • robalzotan